Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$524M |
| 2 |
Meta Platforms (Facebook)
META
|
+$458M |
| 3 |
Otis Worldwide
OTIS
|
+$345M |
| 4 |
T-Mobile US
TMUS
|
+$307M |
| 5 |
AbbVie
ABBV
|
+$280M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$878M |
| 2 |
RTN
Raytheon Company
RTN
|
+$537M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$435M |
| 4 |
Apple
AAPL
|
+$389M |
| 5 |
Accenture
ACN
|
+$216M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.72% |
| 2 | Healthcare | 14.52% |
| 3 | Financials | 12.98% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Communication Services | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VEDL
3151
DELISTED
Vedanta Limited American Depostary Shares (Each representing four equity shares)
VEDL
| $933K | ﹤0.01% |
166,327
+128,728
| +342% | +$609K |
|
3152
Canadian Solar
CSIQ
$1.02B
| $931K | ﹤0.01% |
48,339
-555
| -1% | -$9.87K |
|
3153
Stagwell
STGW
$2.07B
| $931K | ﹤0.01% |
447,972
-334,404
| -43% | -$445K |
|
|
ESTE
3154
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
| $923K | ﹤0.01% |
325,333
+41,735
| +15% | +$102K |
|
3155
Actinium Pharmaceuticals
ATNM
$26.3M
| $918K | ﹤0.01% |
87,113
+67,000
| +333% | +$507K |
|
|
LX
3156
LexinFintech Holdings
LX
$241M
| $917K | ﹤0.01% |
86,250
+9,091
| +12% | +$81K |
|
|
IMDX
3157
Insight Molecular Diagnostics
IMDX
$150M
| $912K | ﹤0.01% |
23,879
+7,511
| +46% | +$388K |
|
3158
Tecnoglass Holdings Inc.
TGLS
$1.93B
| $907K | ﹤0.01% |
166,463
+14,755
| +10% | +$61.8K |
|
|
MBII
3159
DELISTED
Marrone Bio Innovations, Inc.
MBII
| $904K | ﹤0.01% |
772,830
+181,865
| +31% | +$168K |
|
|
MITT
3160
TPG Mortgage Investment Trust
MITT
$222M
| $900K | ﹤0.01% |
94,067
-58,933
| -39% | -$563K |
|
|
UBFO
3161
DELISTED
United Security Bancshares
UBFO
| $900K | ﹤0.01% |
134,619
+6,402
| +5% | +$40.2K |
|
3162
Target Hospitality
TH
$1.51B
| $899K | ﹤0.01% |
532,081
+30,672
| +6% | +$59.5K |
|
|
TTOO
3163
DELISTED
T2 Biosystems, Inc
TTOO
| $899K | ﹤0.01% |
142
-10
| -7% | -$42.5K |
|
|
TLND
3164
DELISTED
Talend S.A. American Depositary Shares
TLND
| $898K | ﹤0.01% |
25,919
+546
| +2% | +$16.1K |
|
3165
Transcontinental Realty Investors
TCI
$352M
| $895K | ﹤0.01% |
29,820
+4,248
| +17% | +$98K |
|
3166
Afya
AFYA
$1.31B
| $891K | ﹤0.01% |
38,038
+13,747
| +57% | +$282K |
|
3167
Colony Bankcorp
CBAN
$465M
| $890K | ﹤0.01% |
75,651
+2,245
| +3% | +$26.1K |
|
3168
Lineage Cell Therapeutics
LCTX
$269M
| $888K | ﹤0.01% |
1,021,544
-655,975
| -39% | -$577K |
|
3169
Stantec
STN
$8.04B
| $885K | ﹤0.01% |
28,679
-115
| -0.4% | -$3.36K |
|
3170
Provident Financial
PROV
$111M
| $883K | ﹤0.01% |
65,853
+4,483
| +7% | +$58.5K |
|
3171
Champions Oncology
CSBR
$74.5M
| $879K | ﹤0.01% |
92,004
+48,269
| +110% | +$411K |
|
|
UROV
3172
DELISTED
Urovant Sciences Ltd.
UROV
| $878K | ﹤0.01% |
89,246
+6,875
| +8% | +$65.9K |
|
|
MJCO
3173
DELISTED
Majesco
MJCO
| $877K | ﹤0.01% |
111,594
+304
| +0.3% | +$1.91K |
|
3174
Takeda Pharmaceutical
TAK
$54.6B
| $873K | ﹤0.01% |
48,742
+16,877
| +53% | +$303K |
|
3175
Hovnanian Enterprises
HOV
$726M
| $872K | ﹤0.01% |
37,298
| – | – |
|
Similar funds
Geode Capital Management's Q2 2020 Portfolio in Review
As of Q2 2020, Geode Capital Management held 4,219 positions worth $467B, up 22% from $384B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q2 2020 filing shows 118 new, 2,550 increased, 1,055 reduced and 119 closed positions. Its largest new stake was Otis Worldwide: 6,650,358 shares worth $377M. The largest sale was Allergan plc, an estimated $878M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q2 2020 buy was Otis Worldwide: 6,650,358 shares worth $377M.
- Geode Capital Management added most to Amazon in Q2 2020, an estimated $524M increase.
- Geode Capital Management's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $435M.
- Geode Capital Management fully exited Allergan plc in Q2 2020, selling an estimated $878M.
- Geode Capital Management's ten largest holdings make up 23% of its $467B portfolio in Q2 2020.
- Geode Capital Management opened 118 new positions and closed 119 in Q2 2020.
- Geode Capital Management's portfolio value rose 22% quarter-over-quarter to $467B.
Based on Geode Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.